BridgeBio is significantly boosted this development of an new therapy for amyloid heart disease, leveraging Attruby. Initial patient data reveals significant benefits for patients diagnosed by the debilitating illness. https://bridgebio439248.prublogger.com/40938269/company-advances-amyloidosis-treatment-through-the-drug